Efficacy and Safety of Ixekizumab in Patients with Refractory Guttate Psoriasis
Latest Information Update: 12 Feb 2025
At a glance
- Drugs Ixekizumab (Primary)
- Indications Guttate psoriasis
- Focus Therapeutic Use
Most Recent Events
- 10 Feb 2025 Planned End Date changed from 1 Jun 2025 to 1 Jun 2026.
- 10 Feb 2025 Planned primary completion date changed from 1 Oct 2024 to 1 Jun 2025.
- 10 Feb 2025 Planned initiation date changed from 1 Apr 2024 to 1 May 2025.